BioCryst Pharmaceuticals, Inc. (BCRX)
NMS – Real vaqt narxi. Valyuta: USD
10.56
+0.22 (2.13%)
Bozor ochiq: Aug 12, 2026, 1:01 PM EDT
10.23
-0.11 (-1.06%)
Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NMS – Real vaqt narxi. Valyuta: USD
10.56
+0.22 (2.13%)
Bozor ochiq: Aug 12, 2026, 1:01 PM EDT
10.23
-0.11 (-1.06%)
Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
Umumiy qarz $836.6M naqd pul zahiralaridan ($155.5M) sezilarli darajada ko'p bo'lib, moliyaviy barqarorlik xavotirlarini keltirib chiqaradi
Jami joriy aktivlar $484.7M jami joriy majburiyatlardan $208.8M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (-1.8) tarmoq o'rtachasidan (-0.8) sezilarli past bo'lib, ehtiyotkor moliyaviy boshqaruvni namoyish etadi
Foiz qoplash koeffitsiyenti (5x) kompaniya qarz to'lovlarini osonlik bilan boshqarishini ko'rsatadi
Kompaniya ijobiy erkin pul oqimi $103.8M generatsiya qiladi, moliyaviy salomatligini qo'llab-quvvatlaydi
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 2.32 | 2.52 | 10 | |
| Tezkor likvidlik nisbati | 2.29 | 1.78 | 10 | |
| Qarz/Kapital nisbati | N/A | -0.80 | 1.0 | |
| Qarz/Aktivlar nisbati | 1.50 | 0.73 | 1.0 | |
| Foiz to‘lov qoplami | 4.54 | -13.90 | 10 | |
| O‘rtacha ball | 6.4 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 271M | 331M | 451M | 875M | 941M |
| Yalpi foyda | 263M | 325M | 437M | 854M | 917M |
| Operatsion daromad | -148M | -104M | -3M | 341M | 385M |
| Sof foyda | -247M | -227M | -89M | 264M | -385M |
| EBITDA | -147M | -102M | -1M | 342M | 387M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | 3.75 | 53.32 | 7.0 |
| Keyingi chorak | -58.38 | -89.52 | 1.0 |
| Joriy yil | -19.58 | -290.21 | 1.0 |
| Keyingi yil | 5.32 | 123.87 | 7.5 |
| O‘rtacha ball | 4.1 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 39.53 | 110.86 | 110.07 | 265.93 | 10 |
| Yil/Yil | 33.61 | 1441.69 | 1400 | 155.68 | 10 |
| 3 yil o‘rtacha | 50.82 | 155.32 | 152.08 | 267.28 | 10 |
| 5 yil o‘rtacha | 201.43 | 86.21 | 86.52 | 156.8 | 10 |
| O‘rtacha ball | 10 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |